TECHNOLOGY FOR GENERATION OF DRUG CANDIDATE LIBRARIES

Information

  • Research Project
  • 2651281
  • ApplicationId
    2651281
  • Core Project Number
    R43DA011878
  • Full Project Number
    1R43DA011878-01
  • Serial Number
    11878
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1998 - 26 years ago
  • Project End Date
    11/30/1998 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1998 - 26 years ago
  • Budget End Date
    11/30/1998 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/8/1998 - 26 years ago
Organizations

TECHNOLOGY FOR GENERATION OF DRUG CANDIDATE LIBRARIES

DESCRIPTION (Adapted from Applicant's Abstract): The goal of this program is to develop a new technology for generating biologically active libraries of compounds for high-throughput screening in drug discovery. This new synthesis method will make it possible to create large numbers of drug-candidate compounds with diverse structures -- many of which are difficult or impossible to produce using other library-synthesis methods. In Phase I, (they) plan to produce eight libraries of compounds. Each library will be created from reactants with structural similarities to ligands for two target receptors -- cannabinoid and K-opioid receptors --and the resulting compounds will be screened for binding to these receptors. Feasibility will be demonstrated if binding is demonstrated in at least 1 in 1000 screened compounds. This would represent an order-of-magnitude improvement over the current "hit rates" achieved using combinatorial-chemistry techniques. Phase II would be aimed at improving hit rates to at least 1 in 100 compounds through structural elucidation and study of receptor binding versus synthetic conditions. The technology would also be extended to other ligand/receptor systems to demonstrate broad applicability. Due to the strong market demand for improved technologies for use with high-throughput screening techniques, we anticipate a straightforward pathway to commercialization. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R43
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
  • Organization Name
    BEND RESEARCH, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BEND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    977018583
  • Organization District
    UNITED STATES